Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: baddtiming who wrote (100717)	4/27/2000 9:57:00 AM
From: vagabond	Respond to of 108040

Re today's IPO's: The AWE offering is so huge (360M shares) that it's hard to imagine it "popping" much. But as I've often said, what do I know? And MTWV looks like it has potential, but unclear. The one today that I'm most curious about is PRCS, mainly because it priced so far below its range but the analyses I've seen point out that -- in contrast to most other biotech companies -- it's already profitable based solely on "collaboration fees" even though it has no drugs in production yet (its prostate-cancer drug has, however, completed Phase-3 testing and will probably be submitted for FDA approval late this year). But there are also some negatives in analyses -- check out the PRCS entry in the "WorldFinance" list for complete background -- worldfinancenet.com ... Vagabond